| Long name | MSX1 Primary Polyclonal Antibody |
| Also known as | MSX1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | MSX1 |
| Specificity | This is a highly specific antibody against MSX1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 200-250/303 |
| Subcellular location | Nucleus |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human MSX1 |
| Gene ID number | 4487 |
| Swiss Prot | P28360 |
| Tested Applications | FCM, IF(ICC), IF(IHC-P), IHC-P, WB |
| Recommended dilutions | FCM(1:20-100), IF(ICC)(1:50-200), IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Goat, Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Acts in cranofacial development and specifically in odontogenesis, Expression in the developing nail bed mesenchyme is important for nail plate thickness and integrity, May play a role in limb-pattern formation, Acts as a transcriptional repressor |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | ECTD3, HYD1, Homeobox protein Hox-7, Homeobox protein MSX-1, MSX1, Msh homeobox 1-like protein, STHAG1, HOX7 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | MSX1 |
| Short name | MSX1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | msh homeobox 1 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048863 and stem cell differentiation and biological process this GO :0050821 and protein stabilization and biological process this GO :0051154 and negative regulation of striated muscle cell differentiation and biological process this GO :0051216 and cartilage development and biological process this GO :0060021 and palate development and biological process this GO :0060325 and face morphogenesis and biological process this GO :0060349 and bone morphogenesis and biological process this GO :0060536 and cartilage morphogenesis and biological process this GO :0061180 and mammary gland epithelium development and biological process this GO :0061312 and BMP signaling pathway involved in heart development and biological process this GO :0071316 and cellular response to nicotine and biological process this GO :0090427 and activation of meiosis and biological process this GO :1902255 and positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator and biological process this GO :2000678 and negative regulation of transcription regulatory region DNA binding and biological process this GO :2001055 and positive regulation of mesenchymal cell apoptotic process and biological process, ECTD3 and HOX7 and HYD1 and STHAG1, MSX1 and IDBG-643455 and ENSBTAG00000010875 and 286872, MSX1 and IDBG-8568 and ENSG00000163132 and 4487, Msx1 and IDBG-159452 and ENSMUSG00000048450 and 17701, nuclei, sequence-specific DNA binding, signal transduction by p53 class mediator and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0045892 and negative regulation of transcription, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000902 and cell morphogenesis and biological process this GO :0000977 and RNA polymerase II regulatory region sequence-specific DNA binding and molecular function this GO :0000982 and RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity and molecular function this GO :0001227 and RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription and molecular function this GO :0001228 and RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and molecular function this GO :0001701 and in utero embryonic development and biological process this GO :0001837 and epithelial to mesenchymal transition and biological process this GO :0002039 and p53 binding and molecular function this GO :0003007 and heart morphogenesis and biological process this GO :0003198 and epithelial to mesenchymal transition involved in endocardial cushion formation and biological process this GO :0003677 and DNA binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005667 and transcription factor complex and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0007507 and heart development and biological process this GO :0007517 and muscle organ development and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0009952 and anterior/posterior pattern specification and biological process this GO :0010463 and mesenchymal cell proliferation and biological process this GO :0021983 and pituitary gland development and biological process this GO :0023019 and signal transduction involved in regulation of gene expression and biological process this GO :0030308 and negative regulation of cell growth and biological process this GO :0030326 and embryonic limb morphogenesis and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030513 and positive regulation of BMP signaling pathway and biological process this GO :0030900 and forebrain development and biological process this GO :0030901 and midbrain development and biological process this GO :0034504 and protein localization to nucleus and biological process this GO :0035115 and embryonic forelimb morphogenesis and biological process this GO :0035116 and embryonic hindlimb morphogenesis and biological process this GO :0035880 and embryonic nail plate morphogenesis and biological process this GO :0042474 and middle ear morphogenesis and biological process this GO :0042475 and odontogenesis of dentin-containing tooth and biological process this GO :0042476 and odontogenesis and biological process this GO :0042481 and regulation of odontogenesis and biological process this GO :0042733 and embryonic digit morphogenesis and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043392 and negative regulation of DNA binding and biological process this GO :0043517 and positive regulation of DNA damage response, this GO :0000977: RNA polymerase II regulatory region sequence-specific DNA binding, this GO :0000977: RNA polymerase II regulatory region sequence-specific DNA binding and also this GO :0000982: RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity and also this GO :0001227: RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription and also this GO :0001228: RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and also this GO :0002039: p53 binding and also this GO :0003677: DNA binding and also this GO :0005515: protein binding and also this GO :0043565: sequence-specific DNA binding, this GO :0000982: RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity, this GO :0001227: RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription, this GO :0001228: RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription, this GO :0002039: p53 binding, this GO :0003677: DNA binding, this GO :0005515: protein binding, this GO :0043565: sequence-specific DNA binding, msh homeobox 1 |
| Identity | 7391 |
| Gene | MSX1 |
| Long gene name | msh homeobox 1 |
| Synonyms gene | HOX7 |
| Synonyms gene name | msh (Drosophila) homeo box homolog 1 (formerly homeo box 7) msh homeobox homolog 1 (Drosophila) |
| Synonyms | HYD1 OFC5 |
| Locus | 4p16, 2 |
| Discovery year | 1993-05-26 |
| GenBank acession | M97676 |
| Entrez gene record | 4487 |
| Pubmed identfication | 1685479 1973146 |
| Classification | NKL subclass homeoboxes and pseudogenes |
| Havana BLAST/BLAT | OTTHUMG00000090335 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue